Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riccardo Provenzani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biochemical Society Transactions|November 18, 2014
C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure-activity relationships and biological activitiesVirpi Talman, Riccardo Provenzani, Gustav Boije af Gennäs, et al.
Analytical and Bioanalytical Chemistry|March 23, 2019
Immobilization of proteolytic enzymes on replica-molded thiol-ene micropillar reactors via thiol-gold interactionSari Tähkä, Jawad Sarfraz, Lauri Urvas, et al.
Scientific Reports|April 13, 2021
Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureusRiccardo Provenzani, Paola San-Martin-Galindo, Ghada Hassan, et al.
Journal of Chemical Information and Modeling|September 11, 2020
Rigorous Computational Study Reveals What Docking Overlooks: Double Trouble from Membrane Association in Protein Kinase C ModulatorsSaara Lautala, Riccardo Provenzani, Artturi Koivuniemi, et al.
International Journal of Pharmaceutics|November 13, 2019
Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applicationsCristian Vergallo, Giulia Torrieri, Riccardo Provenzani, et al.
Plos One|April 12, 2018
Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase CRiccardo Provenzani, Ilari Tarvainen, Giulia Brandoli, et al.
Journal of Medicinal Chemistry|April 3, 2023
Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted AgonistsSaara Lautala, Riccardo Provenzani, Ilari Tarvainen, et al.
Briefings in Bioinformatics|December 28, 2021
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formationAngela Serra, Michele Fratello, Antonio Federico, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biochemical Society Transactions|November 18, 2014
C1 domain-targeted isophthalates as protein kinase C modulators: structure-based design, structure-activity relationships and biological activitiesVirpi Talman, Riccardo Provenzani, Gustav Boije af Gennäs, et al.
Analytical and Bioanalytical Chemistry|March 23, 2019
Immobilization of proteolytic enzymes on replica-molded thiol-ene micropillar reactors via thiol-gold interactionSari Tähkä, Jawad Sarfraz, Lauri Urvas, et al.
Scientific Reports|April 13, 2021
Multisubstituted pyrimidines effectively inhibit bacterial growth and biofilm formation of Staphylococcus aureusRiccardo Provenzani, Paola San-Martin-Galindo, Ghada Hassan, et al.
Journal of Chemical Information and Modeling|September 11, 2020
Rigorous Computational Study Reveals What Docking Overlooks: Double Trouble from Membrane Association in Protein Kinase C ModulatorsSaara Lautala, Riccardo Provenzani, Artturi Koivuniemi, et al.
International Journal of Pharmaceutics|November 13, 2019
Design, synthesis and characterization of a PEGylated stanozolol for potential therapeutic applicationsCristian Vergallo, Giulia Torrieri, Riccardo Provenzani, et al.
Plos One|April 12, 2018
Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase CRiccardo Provenzani, Ilari Tarvainen, Giulia Brandoli, et al.
Journal of Medicinal Chemistry|April 3, 2023
Expanding the Paradigm of Structure-Based Drug Design: Molecular Dynamics Simulations Support the Development of New Pyridine-Based Protein Kinase C-Targeted AgonistsSaara Lautala, Riccardo Provenzani, Ilari Tarvainen, et al.
Briefings in Bioinformatics|December 28, 2021
Computationally prioritized drugs inhibit SARS-CoV-2 infection and syncytia formationAngela Serra, Michele Fratello, Antonio Federico, et al.
Pageof 1